Opthea | OPT - Marktkapitalisierung



Marktkapitalisierung Veränderung Datum
Cochlear AUD 17.05B 2.6B 2025-12
CSL USD 55.89B 20.42B 2025-12
Medical Developments International AUD 62.53M 563.29K 2025-12
Nanosonics AUD 1.2B 25.43M 2025-12
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Pacific Edge NZD 177.94M 49.22M 2026-06
Paradigm Biopharmaceuticals AUD 145.7M 26.92M 2025-12
PYC Therapeutics AUD 965.3M 209.97M 2025-12
Ramsay Health Care AUD 7.93B 537.83M 2025-12
ResMed USD 52.52B 12.57B 2025-12
Telix Pharmaceuticals AUD 5.07B 5.81B 2025-12